18 . December , 2018 - Tuesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Oxycodone and Acetaminophen

Big Image
Generic Name: oxycodone hydrochloride and acetaminophen
Dosage Form: Tablets, usp

CII

Rx only

Oxycodone and Acetaminophen Description

Oxycodone hydrochloride and acetaminophen is supplied in tablet form for oral administration.

Each Oxycodone and Acetaminophen tablet, USP 5 mg*/325 mg tablet contains:

            Oxycodone Hydrochloride, USP . . . . . . . . 5 mg (*equivalent to 4.4815 mg Oxycodone)
            Acetaminophen, USP . . . . . . . . 325 mg

Each Oxycodone and Acetaminophen tablet, USP 7.5 mg*/325 mg tablet contains:

            Oxycodone Hydrochloride, USP . . . . . . . . 7.5 mg (*equivalent to 6.7228 mg Oxycodone)
            Acetaminophen, USP . . . . . . . . 325 mg

Each Oxycodone and Acetaminophen tablet, USP 7.5 mg*/500 mg tablet contains:

            Oxycodone Hydrochloride, USP . . . . . . . . 7.5 mg (*equivalent to 6.7228 mg Oxycodone)
            Acetaminophen, USP . . . . . . . . 500 mg

Each Oxycodone and Acetaminophen tablet, USP 10 mg*/325 mg tablet contains:

            Oxycodone Hydrochloride, USP . . . . . . . . 10 mg (*equivalent to 8.9637 mg Oxycodone)
            Acetaminophen, USP . . . . . . . . 325 mg

Each Oxycodone and Acetaminophen tablet, USP 10 mg*/650 mg tablet contains:

            Oxycodone Hydrochloride, USP . . . . . . . . 10 mg (*equivalent to 8.9637 mg Oxycodone)
            Acetaminophen, USP . . . . . . . . 650 mg

All strengths of Oxycodone and Acetaminophen tablets, USP also contain the following inactive ingredients: crospovidone NF, microcrystalline cellulose NF, povidone USP, pregelatinized starch NF, silicon dioxide NF and stearic acid NF.

Acetaminophen, 4'-hydroxyacetanilide, is a non-opiate, non-salicylate analgesic and antipyretic which occurs as a white, odorless, crystalline powder, possessing a slightly bitter taste. It may be represented by the following structural formula:

Oxycodone, 14-hydroxydihydrocodeinone, is a semisynthetic opioid analgesic which occurs as a white, odorless, crystalline powder having a saline, bitter taste. It is derived from the opium alkaloid thebaine, and may be represented by the following structural formula:

Oxycodone and Acetaminophen - Clinical Pharmacology

The principal ingredient, oxycodone, is a semisynthetic opioid analgesic with multiple actions qualitatively similar to those of morphine; the most prominent involves the central nervous system and organs composed of smooth muscle. The principal actions of therapeutic value of the oxycodone in Oxycodone and Acetaminophen tablets are analgesia and sedation.

Oxycodone is similar to codeine and methadone in that it retains at least one-half of its analgesic activity when administered orally.

Acetaminophen is a non-opiate, non-salicylate analgesic and antipyretic.

Indications and Usage for Oxycodone and Acetaminophen

Oxycodone and Acetaminophen tablets, USP are indicated for the relief of moderate to moderately severe pain.

Contraindications

This product should not be administered to patients who are hypersensitive to oxycodone, acetaminophen, or any other components of this product.

Warnings

Drug Dependence

Oxycodone can produce drug dependence of the morphine type and, therefore, has the potential for being abused. Psychic dependence, physical dependence and tolerance may develop upon repeated administration of Oxycodone and Acetaminophen tablets, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral opioid-containing medications. Like other opioid-containing medications, Oxycodone and Acetaminophen tablets are subject to the Federal Controlled Substances Act (Schedule II).

Precautions

General

Head Injury and Increased Intracranial Pressure: The respiratory depressant effects of opioids and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a pre-existing increase in intracranial pressure. Furthermore, opioids produce adverse reactions which may obscure the clinical course of patients with head injuries.

Acute Abdominal Conditions: The administration of Oxycodone and Acetaminophen tablets or other opioids may obscure the diagnosis or clinical course in patients with acute abdominal conditions.

Special Risk Patients: Oxycodone and Acetaminophen tablets should be given with caution to certain patients such as the elderly or debilitated, and those with severe impairment of hepatic or renal function, hypothyroidism, Addison's disease, and prostatic hypertrophy or urethral stricture.

Information for Patients

Oxycodone may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using Oxycodone and Acetaminophen tablets should be cautioned accordingly.

Drug Interactions

Patients receiving other opioid analgesics, general anesthetics, phenothiazines, other tranquilizers, sedative-hypnotics or other CNS depressants (including alcohol) concomitantly with Oxycodone and Acetaminophen tablets may exhibit an additive CNS depression. When such combined therapy is contemplated, the dose of one or both agents should be reduced.

The concurrent use of anticholinergics with opioids may produce paralytic ileus.

Usage in Pregnancy

Teratogenic Effects; Pregnancy Category C: Animal reproductive studies have not been conducted with oxycodone and acetaminophen. It is also not known whether Oxycodone and Acetaminophen tablets can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Oxycodone and Acetaminophen tablets should not be given to a pregnant woman unless in the judgment of the physician, the potential benefits outweigh the possible hazards.

Nonteratogenic Effects: Use of opioids during pregnancy may produce physical dependence in the neonate.

Labor and Delivery: As with all opioids, administration of Oxycodone and Acetaminophen tablets to the mother shortly before delivery may result in some degree of respiratory depression in the newborn and the mother, especially if higher doses are used.

Nursing Mothers

It is not known whether the active components of this product are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Oxycodone and Acetaminophen tablets are administered to a nursing woman.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Adverse Reactions

The most frequently observed adverse reactions include light-headedness, dizziness, sedation, nausea and vomiting. These effects seem to be more prominent in ambulatory than in nonambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down.

Other adverse reactions include euphoria, dysphoria, constipation, skin rash and pruritus. At higher doses, oxycodone has most of the disadvantages of morphine including respiratory depression.

Drug Abuse and Dependence

Oxycodone and Acetaminophen tablets are a Schedule II controlled substance.

Oxycodone can produce drug dependence and has the potential for being abused (See WARNINGS).

Overdosage

Acetaminophen

Signs and Symptoms: In acute acetaminophen overdosage, dose-dependent, potentially fatal hepatic necrosis is the most serious adverse effect. Renal tubular necrosis, hypoglycemic coma and thrombocytopenia may also occur.

In adults, hepatic toxicity has rarely been reported with acute overdoses of less than 10 grams and fatalities with less than 15 grams. Importantly, young children seem to be more resistant than adults to the hepatotoxic effect of an acetaminophen overdose. Despite this, the measures outlined below should be initiated in any adult or child suspected of having ingested an acetaminophen overdose.

Early symptoms following a potentially hepatotoxic overdose may include: nausea, vomiting, diaphoresis and general malaise. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours post-ingestion.

Treatment: The stomach should be emptied promptly by lavage or by induction of emesis with syrup of ipecac. Patient's estimates of the quantity of a drug ingested are notoriously unreliable. Therefore, if an acetaminophen overdose is suspected, a serum acetaminophen assay should be obtained as early as possible, but no sooner than four hours following ingestion. Liver function studies should be obtained initially and repeated at 24-hour intervals.

The antidote, N-acetylcysteine, should be administered as early as possible, preferably within 16 hours of the overdose ingestion for optimal results, but in any case, within 24 hours. Following recovery, there are no residual, structural, or functional hepatic abnormalities.

Oxycodone

Signs and Symptoms: Serious overdosage with oxycodone is characterized by respiratory depression (a decrease in respiratory rate and/or tidal volume, Cheyne-Stokes respiration, cyanosis), extreme somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and sometimes bradycardia and hypotension. In severe overdosage, apnea, circulatory collapse, cardiac arrest and death may occur.

Treatment: Primary attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and the institution of assisted or controlled ventilation. The opioid antagonist naloxone hydrochloride is a specific antidote against respiratory depression which may result from overdosage or unusual sensitivity to opioids, including oxycodone. Therefore, an appropriate dose of naloxone hydrochloride (usual initial adult dose 0.4 mg to 2 mg) should be administered preferably by the intravenous route, and simultaneously with efforts at respiratory resuscitation (see package insert). Since the duration of action of oxycodone may exceed that of the antagonist, the patient should be kept under continued surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration.

An antagonist should not be administered in the absence of clinically significant respiratory or cardiovascular depression. Oxygen, intravenous fluids, vasopressors and other supportive measures should be employed as indicated.

Gastric emptying may be useful in removing unabsorbed drug.

Oxycodone and Acetaminophen Dosage and Administration

Dosage should be adjusted according to the severity of the pain and the response of the patient. It may occasionally be necessary to exceed the usual dosage recommended below in cases of more severe pain or in those patients who have become tolerant to the analgesic effect of opioids. Oxycodone and Acetaminophen tablets are given orally. The usual adult dosage is one tablet every 6 hours as needed for pain. The total daily of acetaminophen should not exceed 4 grams (maximal daily dose of Oxycodone and Acetaminophen tablets 7.5 mg/325 mg and Oxycodone and Acetaminophen tablets 7.5 mg/500 mg is 8 tablets, and for Oxycodone and Acetaminophen tablets 10 mg/325 mg and Oxycodone and Acetaminophen tablets 10 mg/650 mg is 6 tablets).

How is Oxycodone and Acetaminophen Supplied

Each Oxycodone and Acetaminophen tablet, USP 5 mg/325 mg contains oxycodone hydrochloride 5 mg (equivalent to 4.4815 mg oxycodone) and acetaminophen 325 mg. It is available as a round, white scored tablet debossed with a 512 identification number.

            Bottles of 100 . . . . . . . . NDC No. 0406-0512-01
            Bottles of 500 . . . . . . . . NDC No. 0406-0512-05
            Unit Dose (10x10) . . . . . . . . NDC No. 0406-0512-62
            Punch Card (5 x 30) . . . . . . . . NDC No. 0406-0512-32

Each Oxycodone and Acetaminophen tablet, USP 7.5 mg/325 mg contains oxycodone hydrochloride 7.5 mg (equivalent to 6.7228 mg oxycodone) and acetaminophen 325 mg. It is available as a white to off-white caplet shaped tablet debossed with “M522” on one side and “7.5/325” on the other side.

            Bottles of 100 . . . . . . . . NDC No. 0406-0522-01
            Unit Dose (10x10) . . . . . . . . NDC No. 0406-0522-62

Each Oxycodone and Acetaminophen tablet, USP 7.5 mg/500 mg contains oxycodone hydrochloride 7.5 mg (equivalent to 6.7228 mg oxycodone) and acetaminophen 500 mg. It is available as a white to off-white oval shaped tablet debossed with “M582” on one side and the other side is plain.

            Bottles of 100 . . . . . . . . NDC No. 0406-0582-01
            Unit Dose (10x10) . . . . . . . . NDC No. 0406-0582-62

Each Oxycodone and Acetaminophen tablet, USP 10 mg/325 mg contains oxycodone hydrochloride 10 mg (equivalent to 8.9637 mg oxycodone) and acetaminophen 325 mg. It is available as a white to off-white caplet shaped tablet debossed with “M523” on one side and “10/325” on the other side.

            Bottles of 100 . . . . . . . . NDC No. 0406-0523-01
            Unit Dose (10x10) . . . . . . . . NDC No. 0406-0523-62

Each Oxycodone and Acetaminophen tablet, USP 10 mg/650 mg contains oxycodone hydrochloride 10 mg (equivalent to 8.9637 mg oxycodone) and acetaminophen 650 mg. It is available as a white to off-white capsule shaped tablet debossed with “M562” on one side and the other side is plain.

            Bottles of 100 . . . . . . . . NDC No. 0406-0562-01
            Unit Dose (10x10) . . . . . . . . NDC No. 0406-0562-62

Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature].

Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).

DEA Order Form Required.

Tyco

Healthcare

Mallinckrodt

Mallinckrodt Inc.

St. Louis, Missouri 63134, U.S.A.

Rev. 010205


Oxycodone and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0512 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 5 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 325 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (WHITE) Score 2
Shape ROUND (ROUND) Symbol false
Imprint Code 512 Coating false
Size 12mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0512-01 100 TABLET In 1 BOTTLE None
2 0406-0512-05 500 TABLET In 1 BOTTLE None
3 0406-0512-62 100 TABLET In 1 BLISTER PACK None
4 0406-0512-32 150 TABLET In 1 BLISTER PACK None

Oxycodone and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0522 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 7.5 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 325 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (WHITE (OFF-WHITE)) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M522;7.5/325 Coating false
Size 15mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0522-01 100 TABLET In 1 BOTTLE None
2 0406-0522-62 100 TABLET In 1 BLISTER PACK None

Oxycodone and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0582 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 7.5 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 500 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (WHITE (OFF-WHITE)) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M582 Coating false
Size 18mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0582-01 100 TABLET In 1 BOTTLE None
2 0406-0582-62 100 TABLET In 1 BLISTER PACK None

Oxycodone and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0523 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 10 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 325 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (WHITE (OFF-WHITE)) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M523;10/325 Coating false
Size 16mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0523-01 100 TABLET In 1 BOTTLE None
2 0406-0523-62 100 TABLET In 1 BLISTER PACK None

Oxycodone and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0562 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 10 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 650 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (WHITE (OFF-WHITE)) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M562 Coating false
Size 17mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0562-01 100 TABLET In 1 BOTTLE None
2 0406-0562-62 100 TABLET In 1 BLISTER PACK None

Revised: 08/2006

Recent Drug Updates at DrugIndexOnline:





anakinra injectable anakinra injectable
Generic Name: anakinra (injectable) (an na KIN rah) Brand Names: Kineret What is anakinra? Anakinra reduces the actions of chemicals in the body that are involved in inflammatory and immune responses. Anakinra is used to treat the symptoms of moderate to severe rheumatoid arthritis in pa more...

Cancidas Cancidas
Some commonly used brand names are: In the U.S.— Cancidas Category Antifungal, systemic Description Caspofungin ( kas-poe-FUN-jin) is an antifungal. It is used to help the body overcome serious fungus infections. This medicine is available only with your doctor's prescription, in more...

Comtrex Sinus and Nasal Comtrex Sinus and Nasal
Generic Name: Acetaminophen/Chlorpheniramine/Pseudoephedrine Capsules and Tablets (ah-seet-ah-MIN-oh-fen/klor-fen-EER-a-meen/soo-doe-e-FED-rin) Brand Name: Examples include Alka-Seltzer Plus Cold and Comtrex Sinus and NasalComtrex Sinus and Nasal is used for:Relieving symptoms of colds, hay fe more...

Kantrex Systemic Kantrex Systemic
Some commonly used brand names are: In the U.S.— Amikin 1 Garamycin 2 G-Mycin 2 Jenamicin 2 Kantrex 3 Nebcin 7 Netromycin 5 In Canada— Amikin 1 Garamycin 2 Nebcin 7 Netromycin 5 Note: For quick reference, the following aminoglycosides are numbered to match the corresponding more...

Nipent Nipent
Generic Name: Pentostatin (PEN-toe-sta-tin) Brand Name: NipentThe use of doses higher than specified by the manufacturer of Nipent is not recommended. Severe kidney, liver, lung, and central nervous system problems (toxicities) have occurred in some studies when using higher than recommended do more...

Otocort Sterile Suspension Otocort Sterile Suspension
Generic Name: hydrocortisone, neomycin, and polymyxin B otic (hye droe CORE tih sone, nee oh MY sin, paw lee MIX in B) Brand Names: AK-Spore HC Otic Suspension, Cortatrigen, Cortatrigen Modified, Cortisporin Otic, Cortomycin, Drotic, Masporin Otic, Otimar, Otocort Sterile Solution, Otocor more...

Proctosol-HC Rectal Proctosol-HC Rectal
Some commonly used brand names are: In the U.S.— Anucort-HC 4 Anu-Med HC 4 Anuprep HC 4 Anusol-HC 4 Anutone-HC 4 Anuzone-HC 4 Cort-Dome 4 Cortenema 3 Cortifoam 4 Hemril-HC Uniserts 4 Hemorrhoidal HC 4 Proctocort 4 Proctosol-HC 4 Rectasol-HC 4 In Canada— Betnesol 1 Cortenema 3 Cort more...

Pronestyl Pronestyl
Some commonly used brand names are: In the U.S.— Procan SR Promine Pronestyl Pronestyl-SR In Canada— Procan SR Pronestyl Pronestyl-SR Generic name product may be available in the U.S. and Canada. Category Antiarrhythmic Description Procainamide (proe-KANE-a-mide) is used more...